AtriCure, Inc. (ATRC) Income Statement
ATRC 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsATRC revenue and net income
Where ATRC's revenue goes
2025Each bar shows an amount and its share of revenue. ATRC kept −2.1% of revenue as net income.
ATRC profit margins
ATRC growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +14.9% | +17.4% | +20.9% | +15.2% |
| Gross profit | +14.4% | +17.4% | +21.6% | +15.7% |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
ATRC quarterly EPS vs estimates
AtriCure beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: November 3, 2026 (estimate $0.01).
ATRC income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $534.5M | $465.3M | $399.2M | $330.4M | $274.3M | $206.5M | $230.8M | $201.6M | $174.7M | $155.1M |
| Cost of revenue | $136.8M | $117.8M | $98.9M | $84.4M | $68.5M | $57.2M | $60.5M | $54.5M | $48.6M | $44.0M |
| Gross profit | $397.7M | $347.5M | $300.4M | $245.9M | $205.9M | $149.3M | $170.3M | $147.1M | $126.2M | $111.1M |
| Research & development | $90.2M | $96.2M | $73.9M | $57.3M | $48.5M | $43.1M | $41.2M | $34.7M | $34.1M | $35.8M |
| Sales, general & admin | $311.0M | $291.4M | $253.1M | $231.3M | $19.8M | $150.5M | $162.2M | $129.5M | $117.0M | $106.4M |
| Total operating expenses | $401.2M | $387.5M | $327.1M | $288.6M | $150.7M | $193.5M | $203.5M | $164.2M | $151.1M | $142.2M |
| Operating income | −$3.4M | −$40.0M | −$26.7M | −$42.7M | $55.2M | −$44.2M | −$33.1M | −$17.1M | −$25.0M | −$31.1M |
| Interest income | $4.5M | $4.4M | $3.8M | $2.0M | $466,000 | $1.1M | $2.4M | $1.0M | $227,000 | $227,000 |
| Interest expense | $5.9M | $6.4M | $6.9M | $5.0M | $4.9M | $4.9M | $4.1M | $4.6M | $2.3M | $1.8M |
| Income before taxes | −$10.2M | −$43.7M | −$29.8M | −$46.2M | $50.4M | −$48.0M | −$35.0M | −$20.9M | −$26.9M | −$33.3M |
| Income taxes | $1.3M | $1.0M | $591,000 | $268,000 | $188,000 | $114,000 | $199,000 | $226,000 | $14,000 | $40,000 |
| Net income | −$11.4M | −$44.7M | −$30.4M | −$46.5M | $50.2M | −$48.2M | −$35.2M | −$21.1M | −$26.9M | −$33.3M |
| EBITDA | $16.2M | −$18.5M | −$8.1M | −$31.0M | $65.7M | −$34.7M | −$21.5M | −$7.5M | −$15.5M | −$22.2M |
| EPS (diluted) | −$0.11 | −$0.67 | −$0.76 | −$1.01 | −$1.15 | −$1.19 | −$1.07 | −$0.83 | −$0.95 | −$1.05 |
| Gross margin | 74.4% | 74.7% | 75.2% | 74.4% | 75.0% | 72.3% | 73.8% | 73.0% | 72.2% | 71.6% |
| Operating margin | −0.6% | −8.6% | −6.7% | −12.9% | 20.1% | −21.4% | −14.4% | −8.5% | −14.3% | −20.1% |
| Net margin | −2.1% | −9.6% | −7.6% | −14.1% | 18.3% | −23.3% | −15.2% | −10.5% | −15.4% | −21.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $153.6M | $141.2M | $140.5M | $134.3M | $136.1M | $123.6M | $124.3M | $115.9M | $116.3M | $108.9M | $106.5M | $98.3M |
| Cost of revenue | $35.0M | $31.9M | $35.9M | $32.9M | $34.7M | $31.0M | $31.7M | $29.1M | $30.2M | $28.3M | $27.5M | $24.4M |
| Gross profit | $118.6M | $109.3M | $104.6M | $101.3M | $101.5M | $92.6M | $92.6M | $86.8M | $86.1M | $80.5M | $79.1M | $73.9M |
| Research & development | $26.4M | $24.2M | $22.7M | $22.9M | $29.3M | $22.5M | $35.0M | $21.0M | $19.7M | $19.8M | $20.8M | $20.4M |
| Sales, general & admin | $82.6M | $84.5M | $78.3M | $78.2M | $78.4M | $76.1M | $72.2M | $73.2M | $73.6M | $72.3M | $67.7M | $61.6M |
| Total operating expenses | $109.0M | $108.8M | $101.1M | $101.1M | $107.7M | $98.6M | $107.1M | $94.2M | $93.3M | $91.4M | $87.7M | $82.0M |
| Operating income | $9.7M | $526,000 | $3.5M | $208,000 | −$6.2M | −$6.0M | −$14.5M | −$7.4M | −$7.2M | −$10.9M | −$8.7M | −$8.1M |
| Interest income | $1.2M | $1.2M | $1.3M | $1.2M | $941,000 | $1.0M | $1.2M | $1.3M | $997,000 | $952,000 | $1.0M | $915,000 |
| Interest expense | $1.3M | $1.3M | $1.5M | $2.9M | $1.5M | $1.4M | $1.5M | $1.7M | $1.6M | $1.7M | $1.8M | $1.8M |
| Income before taxes | $9.4M | $394,000 | $2.4M | −$86,000 | −$5.9M | −$6.5M | −$15.3M | −$7.5M | −$7.8M | −$13.1M | −$9.4M | −$9.0M |
| Income taxes | $471,000 | $286,000 | $604,000 | $181,000 | $261,000 | $239,000 | $266,000 | $322,000 | $253,000 | $183,000 | $373,000 | $47,000 |
| Net income | $9.0M | $108,000 | $1.8M | −$267,000 | −$6.2M | −$6.7M | −$15.6M | −$7.9M | −$8.0M | −$13.3M | −$9.8M | −$9.1M |
| EBITDA | $13.8M | $7.0M | $9.0M | $8.0M | $732,000 | −$8,000 | −$9.0M | −$936,000 | −$1.6M | −$7.0M | −$3.4M | −$3.1M |
| EPS (diluted) | $0.18 | $0.00 | $0.06 | −$0.01 | −$0.02 | −$0.14 | −$0.08 | −$0.17 | −$0.17 | −$0.25 | −$0.21 | −$0.20 |
| Gross margin | 77.2% | 77.4% | 74.4% | 75.5% | 74.5% | 74.9% | 74.5% | 74.9% | 74.0% | 74.0% | 74.2% | 75.2% |
| Operating margin | 6.3% | 0.4% | 2.5% | 0.2% | −4.5% | −4.8% | −11.7% | −6.4% | −6.2% | −10.0% | −8.1% | −8.2% |
| Net margin | 5.8% | 0.1% | 1.2% | −0.2% | −4.5% | −5.5% | −12.5% | −6.8% | −6.9% | −12.2% | −9.2% | −9.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in ATRC's financial statements (latest annual report filed February 19, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
ATRC financial results
In fiscal year 2025 (ended December 31, 2025), AtriCure reported revenue of $534.5 million, up 14.9% from the year before. It had a net loss of $11.4 million, a net profit margin of −2.1%. Diluted earnings per share came to −$0.11. Over five years revenue grew at an average rate of 20.9% a year.
See the ATRC stock overview for the latest quote and news, or the ATRC chart for price history and technical indicators.
ATRC income statement FAQ
What is AtriCure's annual revenue?
AtriCure reported total revenue of $534.5 million for fiscal year 2025, which ended on December 31, 2025. That was up 14.9% from $465.3 million the previous year.
Is AtriCure profitable?
No. AtriCure reported a net loss of $11.4 million in fiscal 2025, a net profit margin of −2.1%; its operating margin was −0.6%.
What is AtriCure's gross margin?
AtriCure's gross margin was 74.4% in fiscal 2025: for every $100 of revenue, AtriCure kept $74 after the direct cost of its products and services.
How much does AtriCure spend on research and development?
AtriCure spent $90.2 million on research and development in fiscal 2025, 16.9% of revenue.
How fast is AtriCure growing?
Revenue grew 20.9% a year on average over the last five fiscal years, from $206.5 million to $534.5 million.
What are AtriCure's earnings per share?
AtriCure earned $-0.11 per diluted share in fiscal 2025, compared with $-0.67 a year earlier.
When will AtriCure report its next earnings?
AtriCure is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 after the market closes.
When does AtriCure's fiscal year end?
AtriCure's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 19, 2026.